Alltech enters into agreement to acquire Ridley Ridley and Alltech Inc. announced today they have entered into a plan of arrangement contract under which Alltech will acquire completely of the outstanding share of Ridley, one of the leading commercial animal nutrition companies in THE UNITED STATES, for CAD $40.75 per share. The full total consideration payable to Ridley shareholders is approximately CAD $521 million. The price of CAD $40.75 per share represents a premium of around 23 percent to the 20-day time volume weighted average cost of Ridley'as of April 22 s common shares on the TSX, 2015.Randomization was performed by using a computer-centered randomization list that was generated by the analysis statistician and provided to the analysis pharmacists by the contract research organization. Randomization, that was performed by using Stata software, was balanced in blocks of various sizes, with stratification relating to center. Participants, personnel administering the analysis drugs, physicians, professionals, and the analysis statistician were unaware of the study-group assignments until completion of the study and retrospective evaluation of the samples. The dose was 100 U per kilogram of bodyweight administered intravenously . The placebo was a 0.9 percent saline solution and was given intravenously at the same dose as the active medication.